COVID-19二价疫苗接种对美国养老院居民SARS-CoV-2感染的有效性,2022年11月至2023年3月
本研究采用回顾性队列,纳入2022年11月1日至2023年3月31日76家养老院的6916名居民,评估二价疫苗接种对实验室确诊SARS-CoV-2感染的有效性。调整后疫苗有效性为29%(95%CI 18%至39%),相比未接种或一年前接种为32%(95%CI 20%至42%),相比过去61-365天接种单价疫苗为25%(95%CI 10%至37%)。结论认为二价疫苗提供了额外保护,确保养老院居民及时接种仍是关键预防工具。
要点
- 二价疫苗接种者相比未及时接种者,调整后疫苗有效性为29%(95%CI 18%至39%)。
- 相比未接种或一年前接种者,二价疫苗有效性为32%(95%CI 20%至42%)。
- 相比过去61-365天接种单价疫苗者,二价疫苗有效性为25%(95%CI 10%至37%)。
核心结论
- 二价COVID-19疫苗在研究期间为养老院居民提供了针对SARS-CoV-2感染的额外保护。
- 确保养老院居民及时接种疫苗仍是COVID-19预防的关键工具。
研究设计与样本
- 回顾性队列研究,纳入2022年11月1日至2023年3月31日美国76家养老院的6916名居民。
- 使用Cox比例风险模型估计风险比,疫苗有效性计算为(1-风险比)×100%。
主要发现
- 6916名居民中,3211名(46%)在删失前7天或更早接种了二价疫苗。
- 相比未及时接种者,调整后疫苗有效性为29%(95%CI 18%至39%)。
- 相比未接种或一年前接种者,疫苗有效性为32%(95%CI 20%至42%)。
- 相比过去61-365天接种单价疫苗者,疫苗有效性为25%(95%CI 10%至37%)。
临床怎么用
- 作者认为,确保养老院居民及时接种疫苗仍是COVID-19预防的关键工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Residents of nursing homes remain an epidemiologically important population for COVID-19 prevention efforts, including vaccination. We aim to understand effectiveness of bivalent vaccination for preventing SARS-CoV-2 infections in this population. METHODS: We used a retrospective cohort of nursing home residents from November 1, 2022, through March 31, 2023, to identify new SARS-CoV-2 infections. A Cox proportional hazards model was used to estimate hazard ratios comparing residents with a bivalent vaccination compared with residents not up to date with vaccination recommendations. Vaccine effectiveness was estimated as (1 - Hazard Ratio) * 100. RESULTS: Among 6,916 residents residing in 76 nursing homes included in our cohort, 3,211 (46%) received a bivalent vaccine 7 or more days prior to censoring. Adjusted vaccine effectiveness against laboratory confirmed SARS-CoV-2 infection comparing receipt of a bivalent vaccine versus not up to date vaccine status was 29% (95% Confidence interval 18% to 39%). Vaccine effectiveness for receipt of a bivalent vaccine against residents who were unvaccinated or vaccinated more than a year prior was 32% (95% CI: 20% to 42%,) and was 25% compared with residents who were vaccinated with a monovalent vaccine in the past 61-365 days (95% CI:10% to 37%). CONCLUSIONS: Bivalent COVID-19 vaccines provided additional protection against SARS-CoV-2 infections in nursing home residents during our study time-period, compared to both no vaccination or vaccination more than a year ago and monovalent vaccination 60 - 365 days prior. Ensuring nursing home residents stay up to date with vaccine recommendations remains a critical tool for COVID-19 prevention efforts.
引用
- Hatfield K, Wiegand R, Reddy S, et al. Effectiveness of COVID-19 bivalent vaccination against SARS-CoV-2 infection among residents of US nursing homes, November 2022 - March 2023. Vaccine. 2024. PMID: 39013694. doi:10.1016/j.vaccine.2024.07.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。